Synovus Financial’s Tenaya Therapeutics TNYA Stock Holding History

Synovus Financial’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,600	Closed	-$28.2K	–	930
2024 Q3	$28.2K	Buy	+14,600	New	+$41.2K	﹤0.01%	909

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Synovus Financial's TNYA Position: Q4 2024 in Review

Synovus Financial sold out of Tenaya Therapeutics (TNYA) in Q4 2024, closing a stake of 14,600 shares — an estimated $28.2K sold.

Synovus Financial first reported a position in TNYA in Q3 2024 and held it in 1 quarter. The position peaked at $28.2K in Q3 2024. 88 funds tracked by Wall St. Rank hold TNYA as of Q4 2024.

Synovus Financial reported no remaining Tenaya Therapeutics position as of Q4 2024 after selling out during the quarter.
Synovus Financial sold 14,600 Tenaya Therapeutics shares in Q4 2024, an estimated $28.2K.
Synovus Financial first reported a position in Tenaya Therapeutics in Q3 2024 and held it in 1 quarter.
Synovus Financial's Tenaya Therapeutics position peaked at $28.2K in Q3 2024.
88 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2024.

Based on Synovus Financial's 13F filing for Q4 2024, filed 13 Feb 2025.